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ABSTRACT 
Poor aqueous solubility of drugs results in poor absorption and bioavailability.  The objective of solid dispersion technology is to 
increase the dissolution properties of highly lipophilic drugs, by using different hydrophilic carriers thereby improving their 
bioavailability. This technology is useful for enhancing the dissolution, absorption and therapeutic efficacy of drugs in dosage forms.  
Albendazole is a broad-spectrum antihelmintic agent used for the treatment of a variety of parasitic worm infestations. It is 
practically insoluble in water but slightly soluble in solvents like chloroform, methanol, ethyl acetate, and acetonitrile. The aim of 
our study was to improve the dissolution profile of albendazole using HPMC K 100 LV, Kollidon VA64 and Mannitol as carriers by 
solid dispersion techniques. From the prepared solid dispersion, formulation code CSF5 showed better result where carrier was 
HMPC K 100 LV at 1:10 ratio in solvent evaporation method. The HPMC K 100 LV showed better result for both kneading and 
solvent evaporation methods. Moreover, among the method employed, solvent evaporation method showed better solubility of drug 
at 60 min also at 1:10 ratio which was 78.86%. Results indicated that current formulation of solid dispersion is a promising approach 
for enhancing drug solubility and dissolution. 
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INTRODUCTION 
The term solid dispersion refers to a group of solid 
products consisting of at least two different components, 
generally a hydrophilic matrix and a hydrophobic drug. 
Solid dispersions are a useful pharmaceutical technique 
for increasing the dissolution, absorption and therapeutic 
efficacy of drugs in dosage forms.  The most commonly 
used hydrophilic carriers for solid dispersions include 
polyvinyl pyrrolidone, polyethylene glycols (PEGs), 
Tween-80, sodium lauryl sulphate (SLS) etc. 
1,2,3
.  The 
increase in dissolution rate from SDs can be attributed to 
one or a combination of the following factors: a 
reduction of particle size of the drug, a solubilizing 
effect on the drug by the water soluble carrier, 
enhancement of the wettability and dispersibility of the 
drug by the carrier material, and the possible formation 
of a metastable dispersion that has a greater solubility 
resulting in a quick dissolution rate 
4
.  
The solubility depends on the physical form of the solid, 
the nature and composition of solvent medium 
(temperature and pressure) of system 
5
. According to 
Biopharmaceutical classification system (BCS) which is 
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based on the permeability characteristics of the drugs, 
the poorly aqueous soluble drugs fall under two major 
classes i.e. class II and IV. The BCS class II drugs 
represent low aqueous solubility and high permeability 
characteristics. Attempts to improve the solubility of the 
drugs belonging to class II category can result in an 
enhancement of their bioavailability 
6
. Solid dispersion 
technology is utilized to increase the dissolution rate of 
highly lipophilic drugs, thereby improving their 
bioavailability 
7.
 
Albendazole is a broad-spectrum antihelminthic agent of 
the benzimidazole type. It is a medication used for the 
treatment of a variety of parasitic worm infestations. It 
is useful for giardiasis, trichuriasis, filariasis, neurocysti-
cercosis, hydatid disease and ascariasis 
8
. Its molecular 
formula is C12H15N3O2S and molecular weight is 265.34. 
It has the following chemical structure:  
 
Albendazole is a white to off-white powder. Each white 
to off-white, film-coated tablet contains 200 mg of 
albendazole.  It is soluble in dimethylsulfoxide, strong 
acids, and strong bases. It is slightly soluble in 
methanol, chloroform, ethyl acetate, and acetonitrile. 
Albendazole is practically insoluble in water 
9
. Due to 
the lower solubility in water, the absorption in the GI 
tract is poor 
10
. It is, however, better absorbed than other 
benzimidazole carbamates 
11
. Albendazole concen-
trations are negligible or undetectable in plasma as it is 
rapidly converted to the sulfoxide metabolite prior to 
reaching the systemic circulation. 
The systemic anthelmintic activity has been attributed to 
the primary metabolite, albendazole sulfoxide. Oral 
bioavailability appears to be enhanced when albendazole 
is co-administered with a fatty meal (estimated fat 
content 40 g) as evidenced by higher (up to 5-fold on 
average) plasma concentrations of albendazole sulfoxide 
as compared to the fasted state. Maximal plasma 
concentrations of the drug are typically achieved 2 to 5 
hours after dosing and are on average 1.31 mcg/mL 
(range 0.46 to 1.58 mcg/mL) following oral doses of 
albendazole (400 mg) in 6 hydatid disease patients, 
when administered with a fatty meal. Plasma 
concentrations of albendazole sulfoxide increase in a 
dose-proportional manner over the therapeutic dose 
range. The mean apparent terminal elimination half-life 
of albendazole sulfoxide typically ranges from 8 to 12 
hours in 25 normal subjects, as well as in 14 hydatid and 
8 neurocysticercosis patients 
12
.  
MATERIALS AND METHODS 
Beximco Pharmaceuticals Ltd. was provided the drug 
Albendazole to conduct this study. The other materials 
such as Kollidon VA64, HPMC K 100 LV and Mannitol 
were purchased from local scientific materials suppliers. 
Preparation of Solid Dispersions 
Albendazole (pharmaceutical grade) and the polymers 
mentioned above were used for the preparation of SDs. 
To prepare the solid dispersions of selected polymers 
(Kollidon VA64, HPMC K 100 LV, Mannitol) were 
used at different proportion with the drug Albendazole. 
Then the drug polymer mixtures were homogenized by 
stirring, pulverized and cooled, the obtaining mixtures 
were sieved properly and kept in a screw-capped glass 
vial at desiccator for further use. 
Preparation of Solid Dispersion by Physical mixtures  
To prepare the solid dispersion formulation was 
employed by physical mixing of the selected polymer 
and obtained Albendazole at different ratio (1:2, 1:4, 
1:6, 1:8, 1:10) in individual formulation. The mixture 
was performed by triturating using mortar and pestle for 
about 15 minutes and then kept in a screw-capped glass 
vial at desiccator until use 
12
. 
Preparation of Solid Dispersion by Kneading 
Method 
For preparation of solid dispersion by kneading method, 
a mixture (10 mg) of Albendazole and each of every 
polymer at a ratio of (1:2, 1:4, 1:6, 1:8, 1:10 by weight, 
respectively) were wetted with methanol to form the 
slurry and kneaded thoroughly for 60 min in a glass 
mortar and then dried in an oven at 35ºC till the constant 
weight is reached. The dried mass was pulverized and 
shifted through #60 and obtained product was stored in a 
desiccator until further evaluation.  
Preparation of Solid Dispersion by Solvent 
Evaporation Method 
For this method, about 100 mg of Albendazole was 
weighed accurately in an analytical balance and taken 
into dry and clean glass vials. Then methanol was added 
on each vial 
13
. Then each of every polymer were 
dissolved in the solvent using a vortex mixer to make a 
polymer solution. Drug, polymer and solvent (methanol) 
combination was dried by using hair dryer until solid 
dispersion was formed and the solvent evaporated 
completely. Finally, the formulations were withdrawn 
from vials, crushed in mortar and pestle, passed through 
#60 sieve and the resulted samples were weighed and 
then transferred in clean vials with proper labelling and 
its double amount of lactose was added on each vials as 
adsorbent and mixed well. These formulations were kept 
also in desiccator until the dissolution started. 
Selection of Solvent for solvent evaporation method 
Since the drugs which are usually hydrophobic in nature 
usually chosen for solid dispersions and with them 
hydrophilic polymers are used to enhance the rate of 
dissolution. The selection of proper solvent in solvent 
evaporation method is very much important because its 
removal rate is critical to the quality of dispersion. For 
complete removal of solvent lower temperature and 
reduced pressure can be used. Solvent evaporation 
method is considered as the effective method for SDS 
but the major disadvantage associate with the method is 
that different polymorphic forms of the same drug may 
be formed if different solvents are used 
17. 
Sometimes 
after selecting a proper solvent it was observed that 
complete removal of solvent was very much difficult in 
some SDS. In some cases, large volume of organic 
solvent is required to dissolve both drug and carriers. So 
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to avoid multiple complications care should be taken to 
make proper choice and use of organic solvents during 
formulations.
 
Table 1: Drug carrier ratio for different formulations of Physical Mixture 
Code Method Polymer Drug-Carrier ratio Formulation Code 
 
A 
 
Physical Mixture 
 
 
 
 
HPMC K 100 LV 
1:2 APF1 
1:4 APF2 
1:6 APF3 
1:8 APF4 
1:10 APF5 
 
Kollidon VA64 
1:2 APF6 
1:4 APF7 
1:6 APF8 
1:8 APF9 
1:10 APF10 
Mannitol 1:2 APF11 
1:4 APF12 
1:6 APF13 
1:8 APF14 
1:10 APF15 
 
Table 2: Drug carrier ratio for different formulations of Kneading Method 
Code Method Polymer Drug-Carrier ratio Formulation Code 
 
 
B 
 
 
Kneading Method 
 
 
 
 
HPMC K 100 LV 
1:2 BKF1 
1:4 BKF2 
1:6 BKF3 
1:8 BKF4 
1:10 BKF5 
 
Kollidon VA64 
1:2 BKF6 
1:4 BKF7 
1:6 BKF8 
1:8 BKF9 
1:10 BKF10 
Mannitol 1:2 BKF11 
1:4 BKF12 
1:6 BKF13 
1:8 BKF14 
1:10 BKF15 
 
Table 3: Drug carrier ratio for different formulations of Solvent Evaporation Method 
Code Method Polymer Drug-Carrier ratio Formulation Code 
 
C 
 
Solvent 
Evaporation 
method 
 
 
 
 
HPMC K 100 LV 
1:2 CSF1 
1:4 CSF2 
1:6 CSF3 
1:8 CSF4 
1:10 CSF5 
 
Kollidon VA64 
1:2 CSF6 
1:4 CSF7 
1:6 CSF8 
1:8 CSF9 
1:10 CSF10 
Mannitol 1:2 CSF11 
1:4 CSF12 
1:6 CSF13 
1:8 CSF14 
1:10 CSF15 
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Evaluation of Albendazole Solid Dispersions   
Drug content  
For the estimation of drug content, 10 mg Albendazole 
was transferred into 100 ml volumetric flasks and 
volume was adjusted to 100 ml with distilled water. The 
content of Albendazole was determined using UV-vis 
spectrophotometric at 292 nm against suitable blank. 
In vitro dissolution study 
Solid dispersions formulation was subjected to in vitro 
dissolution by using USP 23 basket method (apparatus 
1). Distilled water was used as a dissolution media with 
50rpm and 37°C temperature. 5 ml of sample was 
withdrawn at regular intervals of time and filtered and 
replaced with 5 ml of fresh dissolution medium, 
dilutions were made and analyzed for Albendazole at 
292 nm by using UV-vis spectrophotometer. 
RESULTS AND DISCUSSION 
The solubility of Albendazole increases with using 
different polymers and also with increasing the 
concentration of the polymers. Among the polymers 
used here to conduct our study, HPMC K 100 LV 
showed better solubility profile compared to other two-
kollidon VA64 and mannitol. In physical mixture 
method, HPMC K 100 LV at 1:10, Kollidon VA64 at 
1:10 and mannitol at 1:10 ratio showed the maximum % 
of drug release against time with 45%, 40.88% and 
30.42% (Figure 1). 
However, in kneading method exhibited better drug 
release profile against time which is almost double 
compared to physical mixture method. HPMC K 100 
LV at 1:10, Kollidon VA64 at 1:10 ratio showed 
81.96% and 71% where mannitol at 1:10 showed only 
around 28% drug release (Figure 2).  
         
 
 
 
Figure 1:   The graphical representation of Time Vs % 
of drug release profile from physical method. 
 
 
                      
 
Figure 2:  The graphical representation of Time Vs % 
of drug release profile from kneading method.
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Among the three formulation technique, solvent 
evaporation method gave the best results for the ratio of 
the polymers of HPMC K 100 LV at 1:10, Kollidon 
VA64 at 1:10 and mannitol at 1:10. Interestingly, even 
mannitol at 1:10 showed almost 50% drug release where 
other two methods around 30% at the same polymer 
ratio. In addition, HPMC K 100 LV at 1:10 and 
Kollidon VA64 at 1:10 ratio revealed almost 80% and 
70% of drug release which is noticeable.  
 
  
 
Figure 3: The graphical representation of Time Vs % of drug release profile from solvent evaporation method. 
From this study, it is clear that the solvent evaporation method with HPMC K100LV at 1:10 ratio exhibit the best result 
which can be presented graphically as follows (Figure 4). 
 
Figure 4: Graphical representation of time Vs % release of pure drug and release of drug from solvent evaporation 
method with HPMC K 100LV at 1:10 ratio 
 
So it is clear evident that solubility of solid dispersion is 
higher in solvent evaporation method as compared to 
other two methods- physical mixtures and kneading 
method. When % of drug release was plotted against 
time the graphical representation showed that release of 
drug from different methods of solid dispersion was 
faster than release of pure Albendazole. And amongst 
the different polymer used, HPMC K 100 LV with 1:10 
ratio showed maximum drug release in solvent 
evaporation method which is shown in figure 4. From 
our discussion we can represent a graphical 
representation showing the effect of maximum drug 
releasing polymer HPMC K100LV in different methods 
employed here to conduct our study. Overall, the 
employed three methods and their % of drug released 
have shown in bellow (Figure 5).  
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Figure 5: The effects of HPMC K100LV on different methods of SDs for Albendazole. 
 
CONCLUSION 
It can be summarized that, by using the three physical 
method, kneading and solvent evaporation methods, 
solid dispersion would be the successfully applicable 
with solvent evaporation technique which have the best 
drug release of percentage at 1:10 ratio of the employed 
polymers. Amongst the methods solvent evaporation 
method showed maximum result as compared to other 
two – physical method and kneading method. Results 
indicated that our prepared solid dispersion is a 
promising approach for enhancing drug solubility and 
dissolution. Several studies have also been conducted 
with the drug Albendazole but we have used different 
polymers here along with different ratios and among the 
polymers used to conduct our study HPMC K100LV 
exhibit better dissolution. 
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